Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis

Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis

BackgroundThe optimal antithrombotic therapy in patients with ST‐segment‐elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI) remains a matter of debate. This updated meta‐analysis investigated the impact of (1) bivalirudin (with and without prolonged infusion)...

Full description

Bibliographic Details
Main Authors: Gregor Fahrni, Mathias Wolfrum, Giovanni Luigi De Maria, Adrian P. Banning, Umberto Benedetto, Rajesh K. Kharbanda
Format: Article
Language:English
Published: Wiley 2016-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
bivalirudin
meta‐analysis
myocardial infarction
percutaneous coronary intervention
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.003515

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.003515

Similar Items